Combination therapy with butyrate and docosahexaenoic acid for keloid fibrogenesis: an in vitro study
An. bras. dermatol; 92 (2), 2017
Abstract: Background: A single, effective therapeutic regimen for keloids has not been established yet, and the development of novel therapeutic approaches is expected. Butyrate, a short-chain fatty acid, and docosahexaenoic acid (DHA), a ω-3 polyunsaturated fatty acid, play multiple anti-inflammat...
Butiratos/uso terapéutico, Ácidos Docosahexaenoicos/uso terapéutico, Fibroblastos, Queloide/tratamiento farmacológico, Proliferación Celular, Células Cultivadas, Colágeno Tipo I, Colágeno Tipo III, Terapia Combinada, Proteínas Serina-Treonina Quinasas, Receptores de Factores de Crecimiento Transformadores beta